Key result
Gene expression profiling identified SERPINA3, FCN3, FREM1, and MNS1 as strong diagnostic biomarkers for heart failure, with FCN3 showing an AUC of 0.972.
Why the study?
To identify possible diagnostic indicators for heart failure and to investigate the function of immune cell infiltration in this pathophysiology.
Are SERPINA3, FCN3, FREM1, and MNS1 valid diagnostic biomarkers for heart failure?
Observational (n=269)
Are SERPINA3, FCN3, FREM1, and MNS1 valid diagnostic biomarkers for heart failure?
Effect estimate: AUC 0.972 (95% CI 0.952-0.992)
Integrated gene expression profiling identified SERPINA3, FCN3, FREM1, and MNS1 as potential diagnostic biomarkers for heart failure, linked to metabolic regulation and immune infiltration.
Requires prospective validation before clinical use; leaves open diagnostic utility in heart failure cohorts.
Background: The purpose of this study was to identify possible diagnostic indicators for heart failure (HF) and to investigate the function of immune cell infiltration in this pathophysiology. Methods: HF datasets from the Gene Expression Metascape database were utilized. R software was used to the identify differentially-expressed genes (DEGs) and perform functional correlation analysis. Least absolute shrinkage and selection operator (LASSO) and Boruta algorithms elimination algorithms were then employed to screen and validate the HF diagnostic variables. Finally, Single-sample Gene Set Enrichment Analysis (ssGSEA) was utilized to assess immune cell infiltration in HF tissues, and the Spearman association between gene expression and immune cell concentration was investigated. Results: A total of 239 DEGs were screened in this study. SERPINA3 (area under the curve, AUC =0.958), FCN3 (AUC =0.972), FREM1 (AUC =0.954), and MNS1 (AUC =0.948) were identified as diagnostic factors of HF. The gene set differentiation analysis (GSVA) (R package “GSVA”) results showed that the high expression of FREM1 and MNS1 genes was involved in bile acid, fatty acid, and heme metabolism, suggesting that the core gene affects the progression of HF by regulating metabolism. Meanwhile, the high expression of FCN3 and SERPINA3 was related to xenobiotic metabolism, inflammatory response, and adipogenesis. Conclusions: Given the importance of immune cell infiltration in the genesis and progression of HF, SERPINA3, FCN3, FREM1, and MNS1 may be used as diagnostic variables for HF.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2022) conducted an observational in Heart failure (n=269). Gene expression profiling (SERPINA3, FCN3, FREM1, MNS1) vs. Normal tissue was evaluated on Diagnostic efficacy (Area Under the Curve) for FCN3 (AUC 0.972, 95% CI 0.952-0.992). Gene expression profiling identified SERPINA3, FCN3, FREM1, and MNS1 as strong diagnostic biomarkers for heart failure, with FCN3 showing an AUC of 0.972.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: